Table 4.
Factor | Comparison | Hazard Ratio | 95% LCL | 95% UCL | P-value |
---|---|---|---|---|---|
AZGP1 IHC N=835; E=382 | Negative/Weak vs. Moderate/Strong | 1.39 | 1.13 | 1.71 | 0.002 |
Log(PSA) | 1 unit increase | 1.43 | 1.21 | 1.68 | <.0001 |
margin | Pos vs. Neg | 1.62 | 1.31 | 2.02 | <.0001 |
SVI | Pos vs. Neg | 2.20 | 1.58 | 3.06 | <.0001 |
ECE | Pos vs. Neg | 1.26 | 1.01 | 1.58 | 0.04 |
Gleason | 3+4 vs. ≤6 | 1.19 | 0.93 | 1.52 | 0.16 |
4+3 vs. ≤6 | 1.99 | 1.47 | 2.69 | <.0001 | |
8–10 vs. ≤6 | 1.43 | 1.02 | 1.99 | 0.04 | |
AZGP1 CISH N=811; E=377 | Negative/Weak vs. Moderate/Strong | 1.28 | 1.04 | 1.58 | 0.02 |
Log(PSA) | 1 unit increase | 1.46 | 1.24 | 1.73 | <.0001 |
margin | Pos vs. Neg | 1.71 | 1.39 | 2.12 | <.0001 |
SVI | Pos vs. Neg | 2.26 | 1.62 | 3.15 | <.0001 |
Gleason | 3+4 vs. <=6 | 1.22 | 0.96 | 1.57 | 0.11 |
4+3 vs. <=6 | 2.12 | 1.57 | 2.86 | <.0001 | |
8–10 vs. <=6 | 1.60 | 1.15 | 2.23 | 0.006 |